|
 
 
Thrombosis Research Section Faculty
Faculty (Secondary Appointment)
Research Interests:
James E. Muntz is Clinical Associate Professor of Medicine and Clinical
Associate Professor of Orthopedic Surgery at Baylor College of Medicine,
and Clinical Associate Professor of Internal Medicine at the University
of Texas Health Science Center. After graduating Phi Beta Kappa from
Indiana University, Dr Muntz received his medical degree from Baylor
College of Medicine and his postgraduate education at St Luke's Episcopal
Hospital and Baylor College of Medicine Affiliated Hospitals. Dr.
Muntz' area of research interest is thromboprophylaxis for venous
thromboembolism, with a special focus on the management of orthopedic
surgery patients. He has participated in numerous clinical trials
of novel anticoagulants and new anticoagulant regimens, and has presented
his findings at more than 400 conferences and has been interviewed
by the television networks ABC, NBC, ESPN and CNN. In 1995, Dr Muntz
received the Outstanding Internist award presented by the Department
of Orthopedic Surgery at Baylor College of Medicine. He currently
serves on the Advisory Board of the American Heart Association. He
is also team physician for the NBA Houston Rockets, the Houston Astros
major league baseball team, and the NFL Houston Texans.
Selected Publications:
1. Risks of venous thrombosis in non-large joint surgery. Am J
Orthop Surg. Pending publication.
2. M. Kwong and JE Muntz. Thromboprophylaxis dosing: the relationship
between timing of first administration, efficacy and safety. Am
J Orthop Surg. 2002;31(11S):16-20.
3. JE Muntz. Optimizing antithrombotic therapy for venous thromboembolism
prophylaxis. Am J Orthop. 2002;31(4S).
4. JE Muntz, AG Turpie, K Bauer, et al. The first synthetic factor
anti XA inhibitor, pentasaccharide (arixtra) compared with low molecular
weight heparin to prevent venous thromboembolism. J South Orthop
Assoc 2001;10(2):119-120.
5. Highlights Newsletter, March 2001. New Therapies: Selective Clotting
Factor Inhibition. Authors: John McCuthen, MD; James Muntz, MD; Louis
M. Kwong, MD; Michael R. Lassen, MD. From venous thromboembolic Disease
After Orthopedic Surgery: Breakthroughs in Prophylaxis from December
15, 2000.
6. JE Muntz. Advances in thrombosis/Hemostasis. World-Wide Medical
Information Service, Scientia Magazine 2001;4(4).
7. JE Muntz, Guest Editor. Issue on Atherosclerosis and Thrombosis.
Scientia Magazine; February 2001.
8. JE Muntz. Risk assessment anticoagulation general surgery patient:
venous thromboembolism - bridging therapy with anticoagulation. Surg
Rounds 2000: 9-11.
9. JE Muntz. Deep vein thrombosis and pulmonary embolism in the perioperative
patient. Am J Manag Care November 2000.
10. Presentation: JE Muntz. Advances in the Prevention and Treatment
of Thrombotic Complications in the Rehabilitation Patient, Wednesday
November 10, 1999, Washington D.C.
 ©1995-2003
Baylor College of Medicine
Email: medicine@bcm.tmc.edu
URL: http://public.bcm.tmc.edu/medicine/muntz.htm (Modified: June 4, 2003)
|